EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+52.23%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$4.46B
AUM Growth
+$4.46B
(+49%)
Cap. Flow
+$210M
Cap. Flow
% of AUM
4.7%
Top 10 Holdings %
Top 10 Hldgs %
30.17%
Holding
145
New
24
Increased
36
Reduced
22
Closed
11
Top Buys
| 1 |
Pliant Therapeutics
PLRX
|
$88.4M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$42.5M |
| 3 |
Trane Technologies
TT
|
$40.2M |
| 4 |
Exact Sciences
EXAS
|
$30.3M |
| 5 |
Fiverr
FVRR
|
$29.4M |
Top Sells
| 1 |
Twilio
TWLO
|
$65.6M |
| 2 |
Xylem
XYL
|
$51.6M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$44M |
| 4 |
Varonis Systems
VRNS
|
$26.7M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$22.7M |
Sector Composition
| 1 | Healthcare | 46.53% |
| 2 | Technology | 23.12% |
| 3 | Industrials | 9.16% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SMAR
26
DELISTED
Smartsheet Inc.
SMAR
| $56.7M | 1.23% |
1,113,000
+166,000
| +18% | +$8.45M |
|
|
GWPH
27
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $53.5M | 1.16% |
436,000
| – | – |
|
|
AIMT
28
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $53.4M | 1.16% |
3,193,117
-657,883
| -17% | -$11M |
|
|
IPHI
29
DELISTED
INPHI CORPORATION
IPHI
| $52.9M | 1.15% |
450,000
| – | – |
|
30
Old Dominion Freight Line
ODFL
$31.1B
| $52.6M | 1.14% |
310,200
+96,700
| +45% | +$16.4M |
|
31
HubSpot
HUBS
$24.9B
| $52M | 1.13% |
232,000
-100,000
| -30% | -$22.4M |
|
32
Trex
TREX
$6.41B
| $48.6M | 1.06% |
374,000
+75,000
| +25% | +$9.76M |
|
33
Vulcan Materials
VMC
$38.1B
| $46.2M | 1% |
398,400
-3,300
| -0.8% | -$382K |
|
34
RingCentral
RNG
$2.74B
| $44.2M | 0.96% |
155,000
+34,000
| +28% | +$9.69M |
|
35
Crown Castle
CCI
$42.3B
| $44.1M | 0.96% |
263,400
-2,500
| -0.9% | -$418K |
|
36
Brookfield Renewable
BEP
$7B
| $43.9M | 0.95% |
916,200
| – | – |
|
37
Neurocrine Biosciences
NBIX
$13.5B
| $43.7M | 0.95% |
357,800
+4,800
| +1% | +$586K |
|
|
38
Zentalis Pharmaceuticals
ZNTL
$123M
| $42.5M | 0.92% |
+914,705
| New | +$42.5M |
|
39
Collegium Pharmaceutical
COLL
$1.25B
| $42.5M | 0.92% |
2,427,976
| – | – |
|
|
40
Trane Technologies
TT
$90.9B
| $42M | 0.91% |
472,000
+452,200
| +2,284% | +$40.2M |
|
41
Aptiv
APTV
$17.3B
| $41.8M | 0.91% |
537,000
-19,500
| -4% | -$1.52M |
|
42
D.R. Horton
DHI
$51.3B
| $40.5M | 0.88% |
730,200
+71,000
| +11% | +$3.94M |
|
|
MNTA
43
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $40.3M | 0.88% |
1,212,000
| – | – |
|
44
Verisk Analytics
VRSK
$37.5B
| $37.4M | 0.81% |
219,500
+61,500
| +39% | +$10.5M |
|
45
KALA BIO
KALA
$105M
| $36.3M | 0.79% |
3,450,000
+497,101
| +17% | +$5.22M |
|
|
BPMC
46
DELISTED
Blueprint Medicines
BPMC
| $36M | 0.78% |
462,000
| – | – |
|
|
MRTX
47
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $34.4M | 0.75% |
301,000
| – | – |
|
|
GBT
48
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $33.8M | 0.73% |
535,000
| – | – |
|
|
TECX
49
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $33.2M | 0.72% |
1,905,307
| – | – |
|
|
ZGNX
50
DELISTED
Zogenix, Inc.
ZGNX
| $32.7M | 0.71% |
1,211,300
-1,630,000
| -57% | -$44M |
|